BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $415
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice TargetHot
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $450 to $415.
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $450 to $415.